ARTICLE SUMMARY:
Becton Dickinson pending acquisition of CareFusion will position it as a leader in the $20 billion medication management business and bolster its already significant commitment to emerging markets.
Becton Dickinson Inc.’s pending acquisition of CareFusion for $12.2 billion will position it as a leader in the $20 billion medication management business and bolster its already significant commitment to emerging markets. It also marks BD as the latest player in what has become the medical device industry’s most interesting dynamic: the race toward consolidation.
